Cerebrospinal	B:C0007806
fluid	I:C0007806
biomarkers	O
as	O
a	O
measure	O
of	O
disease	O
activity	O
and	O
treatment	O
efficacy	O
in	O
relapsing	O
-	I:C0751967
remitting	I:C0751967
multiple	I:C0751967
sclerosis	I:C0751967
.	O

Cerebrospinal	O
fluid	I:C0007806
biomarkers	B:C0005516
as	O
a	O
measure	O
of	O
disease	O
activity	O
and	O
treatment	O
efficacy	O
in	O
relapsing	O
-	I:C0751967
remitting	I:C0751967
multiple	I:C0751967
sclerosis	I:C0751967
.	O

Cerebrospinal	O
fluid	I:C0007806
biomarkers	O
as	O
a	O
measure	O
of	O
disease	O
activity	O
and	O
treatment	O
efficacy	O
in	O
relapsing	B:C0751967
-	I:C0751967
remitting	I:C0751967
multiple	I:C0751967
sclerosis	I:C0751967
.	O

Cerebrospinal	B:C0007806
fluid	I:C0007806
(	O
Cerebrospinal	O
fluid	I:C0007806
)	O
biomarkers	O
can	O
reflect	O
different	O
aspects	O
of	O
the	O
pathophysiology	O
of	O
relapsing	O
-	I:C0751967
remitting	I:C0751967
multiple	I:C0751967
sclerosis	I:C0751967
(	O
relapsing	O
-	I:C0751967
remitting	I:C0751967
multiple	I:C0751967
sclerosis	I:C0751967
)	O
.	O

Cerebrospinal	O
fluid	I:C0007806
(	O
Cerebrospinal	B:C0007806
fluid	I:C0007806
)	O
biomarkers	O
can	O
reflect	O
different	O
aspects	O
of	O
the	O
pathophysiology	O
of	O
relapsing	O
-	I:C0751967
remitting	I:C0751967
multiple	I:C0751967
sclerosis	I:C0751967
(	O
relapsing	O
-	I:C0751967
remitting	I:C0751967
multiple	I:C0751967
sclerosis	I:C0751967
)	O
.	O

Cerebrospinal	O
fluid	I:C0007806
(	O
Cerebrospinal	O
fluid	I:C0007806
)	O
biomarkers	B:C0005516
can	O
reflect	O
different	O
aspects	O
of	O
the	O
pathophysiology	O
of	O
relapsing	O
-	I:C0751967
remitting	I:C0751967
multiple	I:C0751967
sclerosis	I:C0751967
(	O
relapsing	O
-	I:C0751967
remitting	I:C0751967
multiple	I:C0751967
sclerosis	I:C0751967
)	O
.	O

Cerebrospinal	O
fluid	I:C0007806
(	O
Cerebrospinal	O
fluid	I:C0007806
)	O
biomarkers	O
can	O
reflect	O
different	O
aspects	O
of	O
the	O
pathophysiology	O
of	O
relapsing	B:C0751967
-	I:C0751967
remitting	I:C0751967
multiple	I:C0751967
sclerosis	I:C0751967
(	O
relapsing	O
-	I:C0751967
remitting	I:C0751967
multiple	I:C0751967
sclerosis	I:C0751967
)	O
.	O

Cerebrospinal	O
fluid	I:C0007806
(	O
Cerebrospinal	O
fluid	I:C0007806
)	O
biomarkers	O
can	O
reflect	O
different	O
aspects	O
of	O
the	O
pathophysiology	O
of	O
relapsing	O
-	I:C0751967
remitting	I:C0751967
multiple	I:C0751967
sclerosis	I:C0751967
(	O
relapsing	B:C0751967
-	I:C0751967
remitting	I:C0751967
multiple	I:C0751967
sclerosis	I:C0751967
)	O
.	O

Understanding	O
the	O
impact	O
of	O
different	O
disease	B:C0012634
modifying	O
therapies	O
on	O
the	O
Cerebrospinal	O
fluid	I:C0007806
biomarker	O
profile	O
may	O
increase	O
their	O
implementation	O
in	O
clinical	O
practice	O
and	O
their	O
appropriateness	O
for	O
monitoring	O
treatment	O
efficacy	O
.	O

Understanding	O
the	O
impact	O
of	O
different	O
disease	O
modifying	O
therapies	B:C0087111
on	O
the	O
Cerebrospinal	O
fluid	I:C0007806
biomarker	O
profile	O
may	O
increase	O
their	O
implementation	O
in	O
clinical	O
practice	O
and	O
their	O
appropriateness	O
for	O
monitoring	O
treatment	O
efficacy	O
.	O

Understanding	O
the	O
impact	O
of	O
different	O
disease	O
modifying	O
therapies	O
on	O
the	O
Cerebrospinal	B:C0007806
fluid	I:C0007806
biomarker	O
profile	O
may	O
increase	O
their	O
implementation	O
in	O
clinical	O
practice	O
and	O
their	O
appropriateness	O
for	O
monitoring	O
treatment	O
efficacy	O
.	O

Understanding	O
the	O
impact	O
of	O
different	O
disease	O
modifying	O
therapies	O
on	O
the	O
Cerebrospinal	O
fluid	I:C0007806
biomarker	B:C0005516
profile	O
may	O
increase	O
their	O
implementation	O
in	O
clinical	O
practice	O
and	O
their	O
appropriateness	O
for	O
monitoring	O
treatment	O
efficacy	O
.	O

Understanding	O
the	O
impact	O
of	O
different	O
disease	O
modifying	O
therapies	O
on	O
the	O
Cerebrospinal	O
fluid	I:C0007806
biomarker	O
profile	B:C1979963
may	O
increase	O
their	O
implementation	O
in	O
clinical	O
practice	O
and	O
their	O
appropriateness	O
for	O
monitoring	O
treatment	O
efficacy	O
.	O

Understanding	O
the	O
impact	O
of	O
different	O
disease	O
modifying	O
therapies	O
on	O
the	O
Cerebrospinal	O
fluid	I:C0007806
biomarker	O
profile	O
may	O
increase	O
their	O
implementation	O
in	O
clinical	O
practice	O
and	O
their	O
appropriateness	O
for	O
monitoring	B:C0150369
treatment	O
efficacy	O
.	O

This	O
study	B:C2603343
investigated	O
the	O
influence	O
of	O
first	O
-	I:C1708063
line	I:C1708063
(	O
interferon	O
beta	I:C0015980
)	O
and	O
second	O
-	I:C1710038
line	I:C1710038
(	O
natalizumab	O
)	O
therapies	O
on	O
seven	O
Cerebrospinal	O
fluid	I:C0007806
biomarkers	O
in	O
relapsing	O
-	I:C0751967
remitting	I:C0751967
multiple	I:C0751967
sclerosis	I:C0751967
and	O
their	O
correlation	O
with	O
clinical	O
and	O
radiological	O
outcomes	O
.	O

This	O
study	O
investigated	O
the	O
influence	O
of	O
first	B:C1708063
-	I:C1708063
line	I:C1708063
(	O
interferon	O
beta	I:C0015980
)	O
and	O
second	O
-	I:C1710038
line	I:C1710038
(	O
natalizumab	O
)	O
therapies	O
on	O
seven	O
Cerebrospinal	O
fluid	I:C0007806
biomarkers	O
in	O
relapsing	O
-	I:C0751967
remitting	I:C0751967
multiple	I:C0751967
sclerosis	I:C0751967
and	O
their	O
correlation	O
with	O
clinical	O
and	O
radiological	O
outcomes	O
.	O

This	O
study	O
investigated	O
the	O
influence	O
of	O
first	O
-	I:C1708063
line	I:C1708063
(	O
interferon	B:C0015980
beta	I:C0015980
)	O
and	O
second	O
-	I:C1710038
line	I:C1710038
(	O
natalizumab	O
)	O
therapies	O
on	O
seven	O
Cerebrospinal	O
fluid	I:C0007806
biomarkers	O
in	O
relapsing	O
-	I:C0751967
remitting	I:C0751967
multiple	I:C0751967
sclerosis	I:C0751967
and	O
their	O
correlation	O
with	O
clinical	O
and	O
radiological	O
outcomes	O
.	O

This	O
study	O
investigated	O
the	O
influence	O
of	O
first	O
-	I:C1708063
line	I:C1708063
(	O
interferon	O
beta	I:C0015980
)	O
and	O
second	B:C1710038
-	I:C1710038
line	I:C1710038
(	O
natalizumab	O
)	O
therapies	O
on	O
seven	O
Cerebrospinal	O
fluid	I:C0007806
biomarkers	O
in	O
relapsing	O
-	I:C0751967
remitting	I:C0751967
multiple	I:C0751967
sclerosis	I:C0751967
and	O
their	O
correlation	O
with	O
clinical	O
and	O
radiological	O
outcomes	O
.	O

This	O
study	O
investigated	O
the	O
influence	O
of	O
first	O
-	I:C1708063
line	I:C1708063
(	O
interferon	O
beta	I:C0015980
)	O
and	O
second	O
-	I:C1710038
line	I:C1710038
(	O
natalizumab	B:C1172734
)	O
therapies	O
on	O
seven	O
Cerebrospinal	O
fluid	I:C0007806
biomarkers	O
in	O
relapsing	O
-	I:C0751967
remitting	I:C0751967
multiple	I:C0751967
sclerosis	I:C0751967
and	O
their	O
correlation	O
with	O
clinical	O
and	O
radiological	O
outcomes	O
.	O

This	O
study	O
investigated	O
the	O
influence	O
of	O
first	O
-	I:C1708063
line	I:C1708063
(	O
interferon	O
beta	I:C0015980
)	O
and	O
second	O
-	I:C1710038
line	I:C1710038
(	O
natalizumab	O
)	O
therapies	O
on	O
seven	O
Cerebrospinal	B:C0007806
fluid	I:C0007806
biomarkers	O
in	O
relapsing	O
-	I:C0751967
remitting	I:C0751967
multiple	I:C0751967
sclerosis	I:C0751967
and	O
their	O
correlation	O
with	O
clinical	O
and	O
radiological	O
outcomes	O
.	O

This	O
study	O
investigated	O
the	O
influence	O
of	O
first	O
-	I:C1708063
line	I:C1708063
(	O
interferon	O
beta	I:C0015980
)	O
and	O
second	O
-	I:C1710038
line	I:C1710038
(	O
natalizumab	O
)	O
therapies	O
on	O
seven	O
Cerebrospinal	O
fluid	I:C0007806
biomarkers	B:C0005516
in	O
relapsing	O
-	I:C0751967
remitting	I:C0751967
multiple	I:C0751967
sclerosis	I:C0751967
and	O
their	O
correlation	O
with	O
clinical	O
and	O
radiological	O
outcomes	O
.	O

This	O
study	O
investigated	O
the	O
influence	O
of	O
first	O
-	I:C1708063
line	I:C1708063
(	O
interferon	O
beta	I:C0015980
)	O
and	O
second	O
-	I:C1710038
line	I:C1710038
(	O
natalizumab	O
)	O
therapies	O
on	O
seven	O
Cerebrospinal	O
fluid	I:C0007806
biomarkers	O
in	O
relapsing	B:C0751967
-	I:C0751967
remitting	I:C0751967
multiple	I:C0751967
sclerosis	I:C0751967
and	O
their	O
correlation	O
with	O
clinical	O
and	O
radiological	O
outcomes	O
.	O

This	O
study	O
investigated	O
the	O
influence	O
of	O
first	O
-	I:C1708063
line	I:C1708063
(	O
interferon	O
beta	I:C0015980
)	O
and	O
second	O
-	I:C1710038
line	I:C1710038
(	O
natalizumab	O
)	O
therapies	O
on	O
seven	O
Cerebrospinal	O
fluid	I:C0007806
biomarkers	O
in	O
relapsing	O
-	I:C0751967
remitting	I:C0751967
multiple	I:C0751967
sclerosis	I:C0751967
and	O
their	O
correlation	O
with	O
clinical	O
and	O
radiological	O
outcomes	B:C0587081
.	O

We	O
included	O
59	O
relapsing	B:C0751967
-	I:C0751967
remitting	I:C0751967
multiple	I:C0751967
sclerosis	I:C0751967
patients	O
and	O
39	O
healthy	O
controls	O
.	O

The	O
concentrations	O
of	O
C	B:C0963811
-	I:C0963811
X	I:C0963811
-	I:C0963811
C	I:C0963811
motif	I:C0963811
chemokine	I:C0963811
13	I:C0963811
(	O
CXCL13	O
)	O
,	O
C-	O
C	I:C1332831
motif	I:C1332831
chemokine	I:C1332831
ligand	I:C1332831
2	I:C1332831
(	O
C	O
-	I:C1332831
C	I:C1332831
motif	I:C1332831
chemokine	I:C1332831
ligand	I:C1332831
2	I:C1332831
)	O
,	O
chitinase	O
-	I:C3872855
3	I:C3872855
-	I:C3872855
like	I:C3872855
protein	I:C3872855
1	I:C3872855
(	O
chitinase	O
-	I:C3872855
3	I:C3872855
-	I:C3872855
like	I:C3872855
protein	I:C3872855
1	I:C3872855
)	O
,	O
glial	O
fibrillary	I:C0017626
acidic	I:C0017626
protein	I:C0017626
,	O
neurofilament	O
light	I:C0068590
protein	I:C0068590
(	O
neurofilament	O
light	I:C0068590
protein	I:C0068590
)	O
,	O
and	O
neurogranin	O
were	O
determined	O
by	O
ELISA	O
,	O
and	O
chitotriosidase	O
(	O
CHIT1	O
)	O
was	O
analyzed	O
by	O
spectrofluorometry	O
.	O

The	O
concentrations	O
of	O
C	O
-	I:C0963811
X	I:C0963811
-	I:C0963811
C	I:C0963811
motif	I:C0963811
chemokine	I:C0963811
13	I:C0963811
(	O
CXCL13	B:C0963811
)	O
,	O
C-	O
C	I:C1332831
motif	I:C1332831
chemokine	I:C1332831
ligand	I:C1332831
2	I:C1332831
(	O
C	O
-	I:C1332831
C	I:C1332831
motif	I:C1332831
chemokine	I:C1332831
ligand	I:C1332831
2	I:C1332831
)	O
,	O
chitinase	O
-	I:C3872855
3	I:C3872855
-	I:C3872855
like	I:C3872855
protein	I:C3872855
1	I:C3872855
(	O
chitinase	O
-	I:C3872855
3	I:C3872855
-	I:C3872855
like	I:C3872855
protein	I:C3872855
1	I:C3872855
)	O
,	O
glial	O
fibrillary	I:C0017626
acidic	I:C0017626
protein	I:C0017626
,	O
neurofilament	O
light	I:C0068590
protein	I:C0068590
(	O
neurofilament	O
light	I:C0068590
protein	I:C0068590
)	O
,	O
and	O
neurogranin	O
were	O
determined	O
by	O
ELISA	O
,	O
and	O
chitotriosidase	O
(	O
CHIT1	O
)	O
was	O
analyzed	O
by	O
spectrofluorometry	O
.	O

The	O
concentrations	O
of	O
C	O
-	I:C0963811
X	I:C0963811
-	I:C0963811
C	I:C0963811
motif	I:C0963811
chemokine	I:C0963811
13	I:C0963811
(	O
CXCL13	O
)	O
,	O
C-	B:C1332831
C	I:C1332831
motif	I:C1332831
chemokine	I:C1332831
ligand	I:C1332831
2	I:C1332831
(	O
C	O
-	I:C1332831
C	I:C1332831
motif	I:C1332831
chemokine	I:C1332831
ligand	I:C1332831
2	I:C1332831
)	O
,	O
chitinase	O
-	I:C3872855
3	I:C3872855
-	I:C3872855
like	I:C3872855
protein	I:C3872855
1	I:C3872855
(	O
chitinase	O
-	I:C3872855
3	I:C3872855
-	I:C3872855
like	I:C3872855
protein	I:C3872855
1	I:C3872855
)	O
,	O
glial	O
fibrillary	I:C0017626
acidic	I:C0017626
protein	I:C0017626
,	O
neurofilament	O
light	I:C0068590
protein	I:C0068590
(	O
neurofilament	O
light	I:C0068590
protein	I:C0068590
)	O
,	O
and	O
neurogranin	O
were	O
determined	O
by	O
ELISA	O
,	O
and	O
chitotriosidase	O
(	O
CHIT1	O
)	O
was	O
analyzed	O
by	O
spectrofluorometry	O
.	O

The	O
concentrations	O
of	O
C	O
-	I:C0963811
X	I:C0963811
-	I:C0963811
C	I:C0963811
motif	I:C0963811
chemokine	I:C0963811
13	I:C0963811
(	O
CXCL13	O
)	O
,	O
C-	O
C	I:C1332831
motif	I:C1332831
chemokine	I:C1332831
ligand	I:C1332831
2	I:C1332831
(	O
C	B:C1332831
-	I:C1332831
C	I:C1332831
motif	I:C1332831
chemokine	I:C1332831
ligand	I:C1332831
2	I:C1332831
)	O
,	O
chitinase	O
-	I:C3872855
3	I:C3872855
-	I:C3872855
like	I:C3872855
protein	I:C3872855
1	I:C3872855
(	O
chitinase	O
-	I:C3872855
3	I:C3872855
-	I:C3872855
like	I:C3872855
protein	I:C3872855
1	I:C3872855
)	O
,	O
glial	O
fibrillary	I:C0017626
acidic	I:C0017626
protein	I:C0017626
,	O
neurofilament	O
light	I:C0068590
protein	I:C0068590
(	O
neurofilament	O
light	I:C0068590
protein	I:C0068590
)	O
,	O
and	O
neurogranin	O
were	O
determined	O
by	O
ELISA	O
,	O
and	O
chitotriosidase	O
(	O
CHIT1	O
)	O
was	O
analyzed	O
by	O
spectrofluorometry	O
.	O

The	O
concentrations	O
of	O
C	O
-	I:C0963811
X	I:C0963811
-	I:C0963811
C	I:C0963811
motif	I:C0963811
chemokine	I:C0963811
13	I:C0963811
(	O
CXCL13	O
)	O
,	O
C-	O
C	I:C1332831
motif	I:C1332831
chemokine	I:C1332831
ligand	I:C1332831
2	I:C1332831
(	O
C	O
-	I:C1332831
C	I:C1332831
motif	I:C1332831
chemokine	I:C1332831
ligand	I:C1332831
2	I:C1332831
)	O
,	O
chitinase	B:C3872855
-	I:C3872855
3	I:C3872855
-	I:C3872855
like	I:C3872855
protein	I:C3872855
1	I:C3872855
(	O
chitinase	O
-	I:C3872855
3	I:C3872855
-	I:C3872855
like	I:C3872855
protein	I:C3872855
1	I:C3872855
)	O
,	O
glial	O
fibrillary	I:C0017626
acidic	I:C0017626
protein	I:C0017626
,	O
neurofilament	O
light	I:C0068590
protein	I:C0068590
(	O
neurofilament	O
light	I:C0068590
protein	I:C0068590
)	O
,	O
and	O
neurogranin	O
were	O
determined	O
by	O
ELISA	O
,	O
and	O
chitotriosidase	O
(	O
CHIT1	O
)	O
was	O
analyzed	O
by	O
spectrofluorometry	O
.	O

The	O
concentrations	O
of	O
C	O
-	I:C0963811
X	I:C0963811
-	I:C0963811
C	I:C0963811
motif	I:C0963811
chemokine	I:C0963811
13	I:C0963811
(	O
CXCL13	O
)	O
,	O
C-	O
C	I:C1332831
motif	I:C1332831
chemokine	I:C1332831
ligand	I:C1332831
2	I:C1332831
(	O
C	O
-	I:C1332831
C	I:C1332831
motif	I:C1332831
chemokine	I:C1332831
ligand	I:C1332831
2	I:C1332831
)	O
,	O
chitinase	O
-	I:C3872855
3	I:C3872855
-	I:C3872855
like	I:C3872855
protein	I:C3872855
1	I:C3872855
(	O
chitinase	B:C3872855
-	I:C3872855
3	I:C3872855
-	I:C3872855
like	I:C3872855
protein	I:C3872855
1	I:C3872855
)	O
,	O
glial	O
fibrillary	I:C0017626
acidic	I:C0017626
protein	I:C0017626
,	O
neurofilament	O
light	I:C0068590
protein	I:C0068590
(	O
neurofilament	O
light	I:C0068590
protein	I:C0068590
)	O
,	O
and	O
neurogranin	O
were	O
determined	O
by	O
ELISA	O
,	O
and	O
chitotriosidase	O
(	O
CHIT1	O
)	O
was	O
analyzed	O
by	O
spectrofluorometry	O
.	O

The	O
concentrations	O
of	O
C	O
-	I:C0963811
X	I:C0963811
-	I:C0963811
C	I:C0963811
motif	I:C0963811
chemokine	I:C0963811
13	I:C0963811
(	O
CXCL13	O
)	O
,	O
C-	O
C	I:C1332831
motif	I:C1332831
chemokine	I:C1332831
ligand	I:C1332831
2	I:C1332831
(	O
C	O
-	I:C1332831
C	I:C1332831
motif	I:C1332831
chemokine	I:C1332831
ligand	I:C1332831
2	I:C1332831
)	O
,	O
chitinase	O
-	I:C3872855
3	I:C3872855
-	I:C3872855
like	I:C3872855
protein	I:C3872855
1	I:C3872855
(	O
chitinase	O
-	I:C3872855
3	I:C3872855
-	I:C3872855
like	I:C3872855
protein	I:C3872855
1	I:C3872855
)	O
,	O
glial	B:C0017626
fibrillary	I:C0017626
acidic	I:C0017626
protein	I:C0017626
,	O
neurofilament	O
light	I:C0068590
protein	I:C0068590
(	O
neurofilament	O
light	I:C0068590
protein	I:C0068590
)	O
,	O
and	O
neurogranin	O
were	O
determined	O
by	O
ELISA	O
,	O
and	O
chitotriosidase	O
(	O
CHIT1	O
)	O
was	O
analyzed	O
by	O
spectrofluorometry	O
.	O

The	O
concentrations	O
of	O
C	O
-	I:C0963811
X	I:C0963811
-	I:C0963811
C	I:C0963811
motif	I:C0963811
chemokine	I:C0963811
13	I:C0963811
(	O
CXCL13	O
)	O
,	O
C-	O
C	I:C1332831
motif	I:C1332831
chemokine	I:C1332831
ligand	I:C1332831
2	I:C1332831
(	O
C	O
-	I:C1332831
C	I:C1332831
motif	I:C1332831
chemokine	I:C1332831
ligand	I:C1332831
2	I:C1332831
)	O
,	O
chitinase	O
-	I:C3872855
3	I:C3872855
-	I:C3872855
like	I:C3872855
protein	I:C3872855
1	I:C3872855
(	O
chitinase	O
-	I:C3872855
3	I:C3872855
-	I:C3872855
like	I:C3872855
protein	I:C3872855
1	I:C3872855
)	O
,	O
glial	O
fibrillary	I:C0017626
acidic	I:C0017626
protein	I:C0017626
,	O
neurofilament	B:C0068590
light	I:C0068590
protein	I:C0068590
(	O
neurofilament	O
light	I:C0068590
protein	I:C0068590
)	O
,	O
and	O
neurogranin	O
were	O
determined	O
by	O
ELISA	O
,	O
and	O
chitotriosidase	O
(	O
CHIT1	O
)	O
was	O
analyzed	O
by	O
spectrofluorometry	O
.	O

The	O
concentrations	O
of	O
C	O
-	I:C0963811
X	I:C0963811
-	I:C0963811
C	I:C0963811
motif	I:C0963811
chemokine	I:C0963811
13	I:C0963811
(	O
CXCL13	O
)	O
,	O
C-	O
C	I:C1332831
motif	I:C1332831
chemokine	I:C1332831
ligand	I:C1332831
2	I:C1332831
(	O
C	O
-	I:C1332831
C	I:C1332831
motif	I:C1332831
chemokine	I:C1332831
ligand	I:C1332831
2	I:C1332831
)	O
,	O
chitinase	O
-	I:C3872855
3	I:C3872855
-	I:C3872855
like	I:C3872855
protein	I:C3872855
1	I:C3872855
(	O
chitinase	O
-	I:C3872855
3	I:C3872855
-	I:C3872855
like	I:C3872855
protein	I:C3872855
1	I:C3872855
)	O
,	O
glial	O
fibrillary	I:C0017626
acidic	I:C0017626
protein	I:C0017626
,	O
neurofilament	O
light	I:C0068590
protein	I:C0068590
(	O
neurofilament	B:C0068590
light	I:C0068590
protein	I:C0068590
)	O
,	O
and	O
neurogranin	O
were	O
determined	O
by	O
ELISA	O
,	O
and	O
chitotriosidase	O
(	O
CHIT1	O
)	O
was	O
analyzed	O
by	O
spectrofluorometry	O
.	O

The	O
concentrations	O
of	O
C	O
-	I:C0963811
X	I:C0963811
-	I:C0963811
C	I:C0963811
motif	I:C0963811
chemokine	I:C0963811
13	I:C0963811
(	O
CXCL13	O
)	O
,	O
C-	O
C	I:C1332831
motif	I:C1332831
chemokine	I:C1332831
ligand	I:C1332831
2	I:C1332831
(	O
C	O
-	I:C1332831
C	I:C1332831
motif	I:C1332831
chemokine	I:C1332831
ligand	I:C1332831
2	I:C1332831
)	O
,	O
chitinase	O
-	I:C3872855
3	I:C3872855
-	I:C3872855
like	I:C3872855
protein	I:C3872855
1	I:C3872855
(	O
chitinase	O
-	I:C3872855
3	I:C3872855
-	I:C3872855
like	I:C3872855
protein	I:C3872855
1	I:C3872855
)	O
,	O
glial	O
fibrillary	I:C0017626
acidic	I:C0017626
protein	I:C0017626
,	O
neurofilament	O
light	I:C0068590
protein	I:C0068590
(	O
neurofilament	O
light	I:C0068590
protein	I:C0068590
)	O
,	O
and	O
neurogranin	B:C0083727
were	O
determined	O
by	O
ELISA	O
,	O
and	O
chitotriosidase	O
(	O
CHIT1	O
)	O
was	O
analyzed	O
by	O
spectrofluorometry	O
.	O

The	O
concentrations	O
of	O
C	O
-	I:C0963811
X	I:C0963811
-	I:C0963811
C	I:C0963811
motif	I:C0963811
chemokine	I:C0963811
13	I:C0963811
(	O
CXCL13	O
)	O
,	O
C-	O
C	I:C1332831
motif	I:C1332831
chemokine	I:C1332831
ligand	I:C1332831
2	I:C1332831
(	O
C	O
-	I:C1332831
C	I:C1332831
motif	I:C1332831
chemokine	I:C1332831
ligand	I:C1332831
2	I:C1332831
)	O
,	O
chitinase	O
-	I:C3872855
3	I:C3872855
-	I:C3872855
like	I:C3872855
protein	I:C3872855
1	I:C3872855
(	O
chitinase	O
-	I:C3872855
3	I:C3872855
-	I:C3872855
like	I:C3872855
protein	I:C3872855
1	I:C3872855
)	O
,	O
glial	O
fibrillary	I:C0017626
acidic	I:C0017626
protein	I:C0017626
,	O
neurofilament	O
light	I:C0068590
protein	I:C0068590
(	O
neurofilament	O
light	I:C0068590
protein	I:C0068590
)	O
,	O
and	O
neurogranin	O
were	O
determined	O
by	O
ELISA	B:C0014441
,	O
and	O
chitotriosidase	O
(	O
CHIT1	O
)	O
was	O
analyzed	O
by	O
spectrofluorometry	O
.	O

The	O
concentrations	O
of	O
C	O
-	I:C0963811
X	I:C0963811
-	I:C0963811
C	I:C0963811
motif	I:C0963811
chemokine	I:C0963811
13	I:C0963811
(	O
CXCL13	O
)	O
,	O
C-	O
C	I:C1332831
motif	I:C1332831
chemokine	I:C1332831
ligand	I:C1332831
2	I:C1332831
(	O
C	O
-	I:C1332831
C	I:C1332831
motif	I:C1332831
chemokine	I:C1332831
ligand	I:C1332831
2	I:C1332831
)	O
,	O
chitinase	O
-	I:C3872855
3	I:C3872855
-	I:C3872855
like	I:C3872855
protein	I:C3872855
1	I:C3872855
(	O
chitinase	O
-	I:C3872855
3	I:C3872855
-	I:C3872855
like	I:C3872855
protein	I:C3872855
1	I:C3872855
)	O
,	O
glial	O
fibrillary	I:C0017626
acidic	I:C0017626
protein	I:C0017626
,	O
neurofilament	O
light	I:C0068590
protein	I:C0068590
(	O
neurofilament	O
light	I:C0068590
protein	I:C0068590
)	O
,	O
and	O
neurogranin	O
were	O
determined	O
by	O
ELISA	O
,	O
and	O
chitotriosidase	B:C0253005
(	O
CHIT1	O
)	O
was	O
analyzed	O
by	O
spectrofluorometry	O
.	O

The	O
concentrations	O
of	O
C	O
-	I:C0963811
X	I:C0963811
-	I:C0963811
C	I:C0963811
motif	I:C0963811
chemokine	I:C0963811
13	I:C0963811
(	O
CXCL13	O
)	O
,	O
C-	O
C	I:C1332831
motif	I:C1332831
chemokine	I:C1332831
ligand	I:C1332831
2	I:C1332831
(	O
C	O
-	I:C1332831
C	I:C1332831
motif	I:C1332831
chemokine	I:C1332831
ligand	I:C1332831
2	I:C1332831
)	O
,	O
chitinase	O
-	I:C3872855
3	I:C3872855
-	I:C3872855
like	I:C3872855
protein	I:C3872855
1	I:C3872855
(	O
chitinase	O
-	I:C3872855
3	I:C3872855
-	I:C3872855
like	I:C3872855
protein	I:C3872855
1	I:C3872855
)	O
,	O
glial	O
fibrillary	I:C0017626
acidic	I:C0017626
protein	I:C0017626
,	O
neurofilament	O
light	I:C0068590
protein	I:C0068590
(	O
neurofilament	O
light	I:C0068590
protein	I:C0068590
)	O
,	O
and	O
neurogranin	O
were	O
determined	O
by	O
ELISA	O
,	O
and	O
chitotriosidase	O
(	O
CHIT1	B:C0253005
)	O
was	O
analyzed	O
by	O
spectrofluorometry	O
.	O

The	O
concentrations	O
of	O
C	O
-	I:C0963811
X	I:C0963811
-	I:C0963811
C	I:C0963811
motif	I:C0963811
chemokine	I:C0963811
13	I:C0963811
(	O
CXCL13	O
)	O
,	O
C-	O
C	I:C1332831
motif	I:C1332831
chemokine	I:C1332831
ligand	I:C1332831
2	I:C1332831
(	O
C	O
-	I:C1332831
C	I:C1332831
motif	I:C1332831
chemokine	I:C1332831
ligand	I:C1332831
2	I:C1332831
)	O
,	O
chitinase	O
-	I:C3872855
3	I:C3872855
-	I:C3872855
like	I:C3872855
protein	I:C3872855
1	I:C3872855
(	O
chitinase	O
-	I:C3872855
3	I:C3872855
-	I:C3872855
like	I:C3872855
protein	I:C3872855
1	I:C3872855
)	O
,	O
glial	O
fibrillary	I:C0017626
acidic	I:C0017626
protein	I:C0017626
,	O
neurofilament	O
light	I:C0068590
protein	I:C0068590
(	O
neurofilament	O
light	I:C0068590
protein	I:C0068590
)	O
,	O
and	O
neurogranin	O
were	O
determined	O
by	O
ELISA	O
,	O
and	O
chitotriosidase	O
(	O
CHIT1	O
)	O
was	O
analyzed	O
by	O
spectrofluorometry	B:C0037802
.	O

relapsing	B:C0751967
-	I:C0751967
remitting	I:C0751967
multiple	I:C0751967
sclerosis	I:C0751967
patients	O
had	O
higher	O
levels	O
of	O
neurofilament	O
light	I:C0068590
protein	I:C0068590
,	O
CXCL13	O
,	O
chitinase	O
-	I:C3872855
3	I:C3872855
-	I:C3872855
like	I:C3872855
protein	I:C3872855
1	I:C3872855
,	O
and	O
CHIT1	O
than	O
controls	O
(	O
p	O
<	O
0.001	O
)	O
.	O

relapsing	O
-	I:C0751967
remitting	I:C0751967
multiple	I:C0751967
sclerosis	I:C0751967
patients	O
had	O
higher	O
levels	O
of	O
neurofilament	B:C0068590
light	I:C0068590
protein	I:C0068590
,	O
CXCL13	O
,	O
chitinase	O
-	I:C3872855
3	I:C3872855
-	I:C3872855
like	I:C3872855
protein	I:C3872855
1	I:C3872855
,	O
and	O
CHIT1	O
than	O
controls	O
(	O
p	O
<	O
0.001	O
)	O
.	O

relapsing	O
-	I:C0751967
remitting	I:C0751967
multiple	I:C0751967
sclerosis	I:C0751967
patients	O
had	O
higher	O
levels	O
of	O
neurofilament	O
light	I:C0068590
protein	I:C0068590
,	O
CXCL13	B:C0963811
,	O
chitinase	O
-	I:C3872855
3	I:C3872855
-	I:C3872855
like	I:C3872855
protein	I:C3872855
1	I:C3872855
,	O
and	O
CHIT1	O
than	O
controls	O
(	O
p	O
<	O
0.001	O
)	O
.	O

relapsing	O
-	I:C0751967
remitting	I:C0751967
multiple	I:C0751967
sclerosis	I:C0751967
patients	O
had	O
higher	O
levels	O
of	O
neurofilament	O
light	I:C0068590
protein	I:C0068590
,	O
CXCL13	O
,	O
chitinase	B:C3872855
-	I:C3872855
3	I:C3872855
-	I:C3872855
like	I:C3872855
protein	I:C3872855
1	I:C3872855
,	O
and	O
CHIT1	O
than	O
controls	O
(	O
p	O
<	O
0.001	O
)	O
.	O

relapsing	O
-	I:C0751967
remitting	I:C0751967
multiple	I:C0751967
sclerosis	I:C0751967
patients	O
had	O
higher	O
levels	O
of	O
neurofilament	O
light	I:C0068590
protein	I:C0068590
,	O
CXCL13	O
,	O
chitinase	O
-	I:C3872855
3	I:C3872855
-	I:C3872855
like	I:C3872855
protein	I:C3872855
1	I:C3872855
,	O
and	O
CHIT1	B:C0253005
than	O
controls	O
(	O
p	O
<	O
0.001	O
)	O
.	O

Subgroup	B:C1515021
analysis	O
revealed	O
higher	O
neurofilament	O
light	I:C0068590
protein	I:C0068590
,	O
CXCL13	O
and	O
CHIT1	O
levels	O
in	O
patients	O
treated	O
with	I:C0332293
first	O
-	I:C1708063
line	I:C1708063
therapy	I:C1708063
compared	O
to	O
second	O
-	I:C1710038
line	I:C1710038
therapy	I:C1710038
(	O
p	O
=	O
0.008	O
,	O
p	O
=	O
0.001	O
and	O
p	O
=	O
0.026	O
,	O
respectively	O
)	O
.	O

Subgroup	O
analysis	B:C0936012
revealed	O
higher	O
neurofilament	O
light	I:C0068590
protein	I:C0068590
,	O
CXCL13	O
and	O
CHIT1	O
levels	O
in	O
patients	O
treated	O
with	I:C0332293
first	O
-	I:C1708063
line	I:C1708063
therapy	I:C1708063
compared	O
to	O
second	O
-	I:C1710038
line	I:C1710038
therapy	I:C1710038
(	O
p	O
=	O
0.008	O
,	O
p	O
=	O
0.001	O
and	O
p	O
=	O
0.026	O
,	O
respectively	O
)	O
.	O

Subgroup	O
analysis	O
revealed	O
higher	O
neurofilament	B:C0068590
light	I:C0068590
protein	I:C0068590
,	O
CXCL13	O
and	O
CHIT1	O
levels	O
in	O
patients	O
treated	O
with	I:C0332293
first	O
-	I:C1708063
line	I:C1708063
therapy	I:C1708063
compared	O
to	O
second	O
-	I:C1710038
line	I:C1710038
therapy	I:C1710038
(	O
p	O
=	O
0.008	O
,	O
p	O
=	O
0.001	O
and	O
p	O
=	O
0.026	O
,	O
respectively	O
)	O
.	O

Subgroup	O
analysis	O
revealed	O
higher	O
neurofilament	O
light	I:C0068590
protein	I:C0068590
,	O
CXCL13	B:C0963811
and	O
CHIT1	O
levels	O
in	O
patients	O
treated	O
with	I:C0332293
first	O
-	I:C1708063
line	I:C1708063
therapy	I:C1708063
compared	O
to	O
second	O
-	I:C1710038
line	I:C1710038
therapy	I:C1710038
(	O
p	O
=	O
0.008	O
,	O
p	O
=	O
0.001	O
and	O
p	O
=	O
0.026	O
,	O
respectively	O
)	O
.	O

Subgroup	O
analysis	O
revealed	O
higher	O
neurofilament	O
light	I:C0068590
protein	I:C0068590
,	O
CXCL13	O
and	O
CHIT1	B:C0253005
levels	O
in	O
patients	O
treated	O
with	I:C0332293
first	O
-	I:C1708063
line	I:C1708063
therapy	I:C1708063
compared	O
to	O
second	O
-	I:C1710038
line	I:C1710038
therapy	I:C1710038
(	O
p	O
=	O
0.008	O
,	O
p	O
=	O
0.001	O
and	O
p	O
=	O
0.026	O
,	O
respectively	O
)	O
.	O

Subgroup	O
analysis	O
revealed	O
higher	O
neurofilament	O
light	I:C0068590
protein	I:C0068590
,	O
CXCL13	O
and	O
CHIT1	O
levels	O
in	O
patients	O
treated	B:C0332293
with	I:C0332293
first	O
-	I:C1708063
line	I:C1708063
therapy	I:C1708063
compared	O
to	O
second	O
-	I:C1710038
line	I:C1710038
therapy	I:C1710038
(	O
p	O
=	O
0.008	O
,	O
p	O
=	O
0.001	O
and	O
p	O
=	O
0.026	O
,	O
respectively	O
)	O
.	O

Subgroup	O
analysis	O
revealed	O
higher	O
neurofilament	O
light	I:C0068590
protein	I:C0068590
,	O
CXCL13	O
and	O
CHIT1	O
levels	O
in	O
patients	O
treated	O
with	I:C0332293
first	B:C1708063
-	I:C1708063
line	I:C1708063
therapy	I:C1708063
compared	O
to	O
second	O
-	I:C1710038
line	I:C1710038
therapy	I:C1710038
(	O
p	O
=	O
0.008	O
,	O
p	O
=	O
0.001	O
and	O
p	O
=	O
0.026	O
,	O
respectively	O
)	O
.	O

Subgroup	O
analysis	O
revealed	O
higher	O
neurofilament	O
light	I:C0068590
protein	I:C0068590
,	O
CXCL13	O
and	O
CHIT1	O
levels	O
in	O
patients	O
treated	O
with	I:C0332293
first	O
-	I:C1708063
line	I:C1708063
therapy	I:C1708063
compared	O
to	O
second	B:C1710038
-	I:C1710038
line	I:C1710038
therapy	I:C1710038
(	O
p	O
=	O
0.008	O
,	O
p	O
=	O
0.001	O
and	O
p	O
=	O
0.026	O
,	O
respectively	O
)	O
.	O

neurofilament	B:C0068590
light	I:C0068590
protein	I:C0068590
and	O
CHIT1	O
levels	O
correlated	O
with	O
relapse	O
status	I:C0277556
,	O
and	O
neurofilament	O
light	I:C0068590
protein	I:C0068590
and	O
CXCL13	O
levels	O
correlated	O
with	O
the	O
formation	O
of	O
new	O
magnetic	O
resonance	I:C0024485
imaging	I:C0024485
lesions	O
.	O

neurofilament	O
light	I:C0068590
protein	I:C0068590
and	O
CHIT1	B:C0253005
levels	O
correlated	O
with	O
relapse	O
status	I:C0277556
,	O
and	O
neurofilament	O
light	I:C0068590
protein	I:C0068590
and	O
CXCL13	O
levels	O
correlated	O
with	O
the	O
formation	O
of	O
new	O
magnetic	O
resonance	I:C0024485
imaging	I:C0024485
lesions	O
.	O

neurofilament	O
light	I:C0068590
protein	I:C0068590
and	O
CHIT1	O
levels	O
correlated	O
with	O
relapse	B:C0277556
status	I:C0277556
,	O
and	O
neurofilament	O
light	I:C0068590
protein	I:C0068590
and	O
CXCL13	O
levels	O
correlated	O
with	O
the	O
formation	O
of	O
new	O
magnetic	O
resonance	I:C0024485
imaging	I:C0024485
lesions	O
.	O

neurofilament	O
light	I:C0068590
protein	I:C0068590
and	O
CHIT1	O
levels	O
correlated	O
with	O
relapse	O
status	I:C0277556
,	O
and	O
neurofilament	B:C0068590
light	I:C0068590
protein	I:C0068590
and	O
CXCL13	O
levels	O
correlated	O
with	O
the	O
formation	O
of	O
new	O
magnetic	O
resonance	I:C0024485
imaging	I:C0024485
lesions	O
.	O

neurofilament	O
light	I:C0068590
protein	I:C0068590
and	O
CHIT1	O
levels	O
correlated	O
with	O
relapse	O
status	I:C0277556
,	O
and	O
neurofilament	O
light	I:C0068590
protein	I:C0068590
and	O
CXCL13	B:C0963811
levels	O
correlated	O
with	O
the	O
formation	O
of	O
new	O
magnetic	O
resonance	I:C0024485
imaging	I:C0024485
lesions	O
.	O

neurofilament	O
light	I:C0068590
protein	I:C0068590
and	O
CHIT1	O
levels	O
correlated	O
with	O
relapse	O
status	I:C0277556
,	O
and	O
neurofilament	O
light	I:C0068590
protein	I:C0068590
and	O
CXCL13	O
levels	O
correlated	O
with	O
the	O
formation	O
of	O
new	O
magnetic	B:C0024485
resonance	I:C0024485
imaging	I:C0024485
lesions	O
.	O

neurofilament	O
light	I:C0068590
protein	I:C0068590
and	O
CHIT1	O
levels	O
correlated	O
with	O
relapse	O
status	I:C0277556
,	O
and	O
neurofilament	O
light	I:C0068590
protein	I:C0068590
and	O
CXCL13	O
levels	O
correlated	O
with	O
the	O
formation	O
of	O
new	O
magnetic	O
resonance	I:C0024485
imaging	I:C0024485
lesions	B:C0221198
.	O

Furthermore	O
,	O
we	O
found	O
an	O
association	O
between	O
inflammatory	O
and	O
degenerative	O
biomarkers	B:C0005516
.	O

The	O
results	O
indicate	O
that	O
Cerebrospinal	B:C0007806
fluid	I:C0007806
levels	O
of	O
neurofilament	O
light	I:C0068590
protein	I:C0068590
,	O
CXCL13	O
,	O
chitinase	O
-	I:C3872855
3	I:C3872855
-	I:C3872855
like	I:C3872855
protein	I:C3872855
1	I:C3872855
,	O
and	O
CHIT1	O
correlate	O
with	O
the	O
clinical	O
and	O
/	O
or	O
radiological	O
disease	O
activity	O
,	O
providing	O
additional	O
dimensions	O
in	O
the	O
assessment	O
of	O
treatment	O
efficacy	O
.	O

The	O
results	O
indicate	O
that	O
Cerebrospinal	O
fluid	I:C0007806
levels	O
of	O
neurofilament	B:C0068590
light	I:C0068590
protein	I:C0068590
,	O
CXCL13	O
,	O
chitinase	O
-	I:C3872855
3	I:C3872855
-	I:C3872855
like	I:C3872855
protein	I:C3872855
1	I:C3872855
,	O
and	O
CHIT1	O
correlate	O
with	O
the	O
clinical	O
and	O
/	O
or	O
radiological	O
disease	O
activity	O
,	O
providing	O
additional	O
dimensions	O
in	O
the	O
assessment	O
of	O
treatment	O
efficacy	O
.	O

The	O
results	O
indicate	O
that	O
Cerebrospinal	O
fluid	I:C0007806
levels	O
of	O
neurofilament	O
light	I:C0068590
protein	I:C0068590
,	O
CXCL13	B:C0963811
,	O
chitinase	O
-	I:C3872855
3	I:C3872855
-	I:C3872855
like	I:C3872855
protein	I:C3872855
1	I:C3872855
,	O
and	O
CHIT1	O
correlate	O
with	O
the	O
clinical	O
and	O
/	O
or	O
radiological	O
disease	O
activity	O
,	O
providing	O
additional	O
dimensions	O
in	O
the	O
assessment	O
of	O
treatment	O
efficacy	O
.	O

The	O
results	O
indicate	O
that	O
Cerebrospinal	O
fluid	I:C0007806
levels	O
of	O
neurofilament	O
light	I:C0068590
protein	I:C0068590
,	O
CXCL13	O
,	O
chitinase	B:C3872855
-	I:C3872855
3	I:C3872855
-	I:C3872855
like	I:C3872855
protein	I:C3872855
1	I:C3872855
,	O
and	O
CHIT1	O
correlate	O
with	O
the	O
clinical	O
and	O
/	O
or	O
radiological	O
disease	O
activity	O
,	O
providing	O
additional	O
dimensions	O
in	O
the	O
assessment	O
of	O
treatment	O
efficacy	O
.	O

The	O
results	O
indicate	O
that	O
Cerebrospinal	O
fluid	I:C0007806
levels	O
of	O
neurofilament	O
light	I:C0068590
protein	I:C0068590
,	O
CXCL13	O
,	O
chitinase	O
-	I:C3872855
3	I:C3872855
-	I:C3872855
like	I:C3872855
protein	I:C3872855
1	I:C3872855
,	O
and	O
CHIT1	B:C0253005
correlate	O
with	O
the	O
clinical	O
and	O
/	O
or	O
radiological	O
disease	O
activity	O
,	O
providing	O
additional	O
dimensions	O
in	O
the	O
assessment	O
of	O
treatment	O
efficacy	O
.	O

The	O
results	O
indicate	O
that	O
Cerebrospinal	O
fluid	I:C0007806
levels	O
of	O
neurofilament	O
light	I:C0068590
protein	I:C0068590
,	O
CXCL13	O
,	O
chitinase	O
-	I:C3872855
3	I:C3872855
-	I:C3872855
like	I:C3872855
protein	I:C3872855
1	I:C3872855
,	O
and	O
CHIT1	O
correlate	O
with	O
the	O
clinical	O
and	O
/	O
or	O
radiological	O
disease	O
activity	O
,	O
providing	O
additional	O
dimensions	O
in	O
the	O
assessment	B:C0220825
of	O
treatment	O
efficacy	O
.	O

